46,000 Shares of Aveanna Healthcare Holdings Inc. $AVAH Bought by Oakmont Investment Advisors Inc.

Oakmont Investment Advisors Inc. bought a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 46,000 shares of the company’s stock, valued at approximately $571,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Farther Finance Advisors LLC boosted its stake in shares of Aveanna Healthcare by 217.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company’s stock worth $37,000 after acquiring an additional 2,039 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Diversified Trust Co increased its stake in Aveanna Healthcare by 14.9% in the 1st quarter. Diversified Trust Co now owns 22,293 shares of the company’s stock valued at $144,000 after purchasing an additional 2,893 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Aveanna Healthcare by 22.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock valued at $113,000 after purchasing an additional 3,172 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in Aveanna Healthcare by 104.7% in the 3rd quarter. Nisa Investment Advisors LLC now owns 11,181 shares of the company’s stock valued at $139,000 after purchasing an additional 5,720 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Stock Up 1.9%

Shares of NASDAQ AVAH opened at $12.99 on Thursday. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $14.71. The company has a market capitalization of $2.83 billion, a PE ratio of 10.56, a price-to-earnings-growth ratio of 0.78 and a beta of 1.95. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The firm’s 50-day moving average is $13.04 and its two-hundred day moving average is $9.71.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.77 EPS for the current fiscal year.

Insider Transactions at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the sale, the insider owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This represents a 15.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Robert Williams, Jr. sold 2,250,000 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $11.50, for a total value of $25,875,000.00. Following the sale, the insider owned 12,315,892 shares in the company, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 48,566,081 shares of company stock worth $558,509,932 in the last quarter. Insiders own 5.30% of the company’s stock.

Analyst Ratings Changes

AVAH has been the topic of a number of research analyst reports. Raymond James Financial boosted their target price on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Royal Bank Of Canada upped their target price on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 24th. JPMorgan Chase & Co. raised their price target on Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a research report on Monday, September 14th. BMO Capital Markets lifted their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Finally, UBS Group lifted their price target on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $14.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is a provider of home-based healthcare services in the United States. The company serves patients across the lifespan, with a particular focus on children and adults who require ongoing medical support, skilled nursing or assistance with daily activities.

Aveanna’s services include private-duty nursing, home health care, hospice and palliative care, therapy, medical solutions and personal-care services. Its clinicians and caregivers support patients with complex medical conditions, disabilities and other needs in their homes and community settings, working with patients, families, physicians and healthcare organizations.

The company was established in 2016 through the combination of Pediatric Services of America and Epic Health Services and became a publicly traded company in 2021.